Abstract
Arginase serum levels were increased in human African trypanosomiasis patients and returned to control values after treatment. Arginase hydrolyzes L-arginine to L-ornithine, which is essential for parasite growth. Moreover, L-arginine depletion impairs immune functions. Arginase may be considered as a biomarker for treatment efficacy. © 2013, American Society for Microbiology.
Cite
CITATION STYLE
Nzoumbou-Boko, R., Dethoua, M., Gabriel, F., Buguet, A., Cespuglio, R., Courtois, P., … Vincendeau, P. (2013). Serum Arginase, a biomarker of treatment efficacy in human African trypanosomiasis. Journal of Clinical Microbiology, 51(7), 2379–2381. https://doi.org/10.1128/JCM.03371-12
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.